Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
102 Cards in this Set
- Front
- Back
What is the DOC for stroke prevention in those with CAD?
|
ASPIRIN
|
|
MOA of Aspirin?
|
IRREVERSIBLE COX (-)
platelet aggregation inhibitor |
|
Agent that inhibits degranulation, minimizing ACP and TXA release and is also a uricosuric agent?
|
Sulfinpyrazone
|
|
What is a uricosuric agent?
|
blocks proximal tubule resorption of uric acid
(so, much uric acid goes out with the urine --> uric-os-uric) |
|
MOA of Dipyridamole (Persantine) ?
|
phosphodiesterase (-); therefore increases cAMP and this inhibits TXA2
|
|
In combination with warfarin what is Dipyridamole used for?
|
to prevent thromboembolic events of cardiac valve replacement
|
|
In combination with aspirin what is Dipyridamole used for?
|
chronic platelet aggregation inhibition
|
|
What drug is used in conjunction with radioactively tagged thallium or sestamibi, to facilitate max delivery of these agents to HEALTHY bv's of the heart?
|
Dipyridamole (persantine)
|
|
MOA of Clopidogrel?
|
Inhibits the ADP-mediated platelet aggregation process; thus powerful platelet aggregation (-)
|
|
All patients who receive stents, as a standard of practice, are prescribed what?
|
Clopidogrel
|
|
What is used for prophylaxis of MI in those with CAD?
|
Clopidogrel
|
|
What is used for prophylaxis of CVA for those with carotid artery disease?
|
Clopidogrel
|
|
List the 2 other pharmaceuticals with similar MOA as Clopidogrel?
|
Ticlopidine
prasugrel |
|
How are Glycoprotein IIbIIIa antagonists administered?
|
by IV drip
|
|
What are the 3 Glycoprotein IIbIIa antagonists?
|
eptifibatide
abciximab tirofiban |
|
MOA of eptifibatide, abciximab, and tirofiban?
|
glycoprotein IIbIIIa antagonists; platelet aggregation is powerfully (-)
|
|
What agents are used to minimize the risk for recurrent MI, recurrent unstable angina, and to decrease the risk of stent re-occlusion following coronary artery angioplasty?
|
Glycoprotein IIbIIIa antagonists
eptifibatide, abciximab, and tirofiban |
|
MOA of heparin?
|
binds antithrombin III and enhances its activity of (-) clotting factors IX, X, XI, XII and factors II and XIII
|
|
What clotting factors does Antithrombin III normally bind and inhibit?
|
IX, X, XI and XII
also affects factor II and XIII |
|
What is the major drug for pulmonary embolus, DVT, acute phase of MI, and in dialysis machines?
|
HEPARIN
|
|
In case of Heparin overdose what may be used as the antidote?
|
protamine sulfate
|
|
Low molecular weight heparin (LMWH) includes what 3 agents?
|
dalteparin, enoxaparin, tinzaparin
|
|
MOA of LMWH?
|
inhibits primarily factor X
|
|
How is LMWH advantageous?
|
serum anticoaguglation studies do not need to be monitored
|
|
Do serum anticoagulation studies need to be monitored in LMWH therapy or in heparin use?
|
Regular heparin use
|
|
What agents antagonize vit K-dependent activation of factors X, IX, VII, II?
|
Warfarin (coumadin) and dicumarol
|
|
How long does it take for therapeutic effect of Warfarin to take place?
|
3-5 days
|
|
What is the major ADR of Warfarin?
|
hemorrhage
|
|
This anticoagulant is CI in pregnancy?
|
Warfarin
|
|
Overdose of Warfarin (coumadin) may be counteracted by what?
|
vitaminK
|
|
What is the DOC for stroke prevention in those with CAD?
|
ASPIRIN
|
|
MOA of Aspirin?
|
IRREVERSIBLE COX (-)
platelet aggregation inhibitor |
|
Agent that inhibits degranulation, minimizing ACP and TXA release and is also a uricosuric agent?
|
Sulfinpyrazone
|
|
What is a uricosuric agent?
|
blocks proximal tubule resorption of uric acid
(so, much uric acid goes out with the urine --> uric-os-uric) |
|
MOA of Dipyridamole (Persantine) ?
|
phosphodiesterase (-); therefore increases cAMP and this inhibits TXA2
|
|
In combination with warfarin what is Dipyridamole used for?
|
to prevent thromboembolic events of cardiac valve replacement
|
|
In combination with aspirin what is Dipyridamole used for?
|
chronic platelet aggregation inhibition
|
|
What drug is used in conjunction with radioactively tagged thallium or sestamibi, to facilitate max delivery of these agents to HEALTHY bv's of the heart?
|
Dipyridamole (persantine)
|
|
MOA of Clopidogrel?
|
Inhibits the ADP-mediated platelet aggregation process; thus powerful platelet aggregation (-)
|
|
All patients who receive stents, as a standard of practice, are prescribed what?
|
Clopidogrel
|
|
This agent binds to antithrombin and activates it to selectively inhibit only factor X?
|
Fondaparinux
|
|
What is Fondaparinux used for?
|
DVT and patients with a heparin hypersensitivity
|
|
What is the MOA of Argatroban, bivalirudin, and lepirudin?
|
Direct thrombin (-); bind to a block the active site on thrombin (factor II)
|
|
How are Argatroban, bivalirudin, and lepirudin administered?
|
IV
|
|
What direct thrombin (-) is hepatotoxic?
|
Argatroban
|
|
What direct thrombin inhibitor has been associated with fatal anaphylactic rxns?
|
Lepirudin
|
|
What agents prevent coagulation?
|
anticoagulants;
heparin, LMWH, warfarin/dicumarol, fondaparinux, and the direct thrombin inhibitors |
|
What agents lyse or break preformed clots?
|
throbolytics;
streptokinase, urokinase, and tPA |
|
Some uses of what agents include PE, DVT, acute MI, arterial thrombosis, and occluded access shunts?
|
Thrombolytics
|
|
MOA of streptokinase?
|
ACTIVATES PLASMINOGEN; and also catalyzes degadation of fibrinogen and factors V and VII
|
|
MOA of Urokinase?
|
activating plasminogen
|
|
What is Urokinase derived from?
|
fetal renal cells
|
|
What is streptokinase derived from?
|
bacteria
|
|
Which agent is less antigenic; streptokinase or urokinase?
|
Urokinase because it is derived from fetal renal cells and not bacteria
|
|
What agents will ONLY activate plasmin that is already bound to fibrin?
|
tPA; also known as alteplase
|
|
This agent is unlike the other thrombolytics in that is targets just the areas that have already begun to form clots, what is the agent?
|
tPA; also known as alteplase
|
|
What 2 agents have the same MOA as tPA?
|
Tenecteplase and reteplase
|
|
tPA is very effective for what 3 things?
|
MI, PE, and acute ischemic stroke
|
|
Which agent is a recombinant non-glycosylated form with a longer half-life than alteplase? Tenecteplase OR reteplase?
|
Reteplase
|
|
What are the 4 classes of antiarrhythmics?
|
silly bunnies punch cats
Sodium Channel Blocker Beta Blocker Potassium Channel Blockers Calcium Channel Blockers |
|
Class 1 antiarrhythmics are what?
|
sodium channel blockers
|
|
What effect do sodium channel blockers have?
|
decrease the upstoke during depol and overall, decrease the cardiac AP amplitude
|
|
What are the class 1A antiarrythmics?
|
quinidine
procainamide |
|
What are the Class 1B antiarrhythimcs?
|
lidocaine and phenytoin
|
|
what is the class 1C antiarrhythmic?
|
flecainide
|
|
Class 1A antiarrhythmics serve to slow what phase of depolarization?
|
phase 0
|
|
Quinidine is effective for what?
|
both atrial and ventricular tachycardias
|
|
Procainamide is used for what?
|
ventricular and supraventricular tachycardias
|
|
What adverse effects may the Class1A antiarrhymics have?
|
may cause hypotension as well as QT prolongation
|
|
What class of antiarrhythmics are particularly suited to minimizing and controlling abnormal arrhythmias that are generated from abnormal automaticity?
|
Class 1B
|
|
Which class 1B antiarrhythmic is rarely used as as an antiarrhythmic?
|
Phenytoin
|
|
What is lidocaine used for?
|
ventricular tachycardia or ventricular fivrillation
|
|
What class of drugs mildly sow phase 0 while significantly shortening phase 3 repolarization?
|
Class 1B
|
|
This agent is effective in minimizing the chance of ectopic beats in the ventricle but is rarely used because of the risk of causing death?
|
Flecainide
|
|
What are the Class II antiarrhythmic agents?
|
Propranolol and Metoprolol
|
|
Which Class II antiarrhythmic agent is preferred? and why?
|
Metoprolol; because it's beta-one specific
|
|
What class of antiarrhythimc agents are particularly suited to reateing sympathetically-driven tachyarrhythmias, as well as atrial fibrillation, atrial flutter, and AV nodal re-entrant tachycardia?
|
Class II antiarrhythmic agents
|
|
Class II antiarrhythimcs supress what phase?
|
Phase 4
|
|
This agent can be used post-MI prophylactically b/c the #1 cause of death post-MI is arrhythmia?
|
Metoprolol
|
|
This class of antiarrhythmics increase action potentioal duration as phase 3 depolarization is prolonged?
|
class III
|
|
What agents are Class III antiarrhythmics?
|
Bretylium and Amiodarone
|
|
What is the first line aent for many ventricular and supraventricular arrhythmias?
|
Amiodarone
|
|
What are the side effects of Amiodarone? (2)
|
pulmonary fibrosis as well as thyroid function derangements
|
|
What agent potentiates digitoxin toxicity ?
|
quinidine
|
|
What agent causes reversible drug-induced lupu in 1/4th to 1/3rd of patients who take it on a chronic basis?
|
Procainamide
|
|
Verapaiml and diltiazem are useful in controlling what?
|
ventricular rates in atrial fibrillation
|
|
What agents are Class IV antiarrhythmics?
|
calcium channel blockers;
diltiazem and verapamil |
|
This class of antiarrhythmics slow calcium conduction in tissues dependent on it (such as the AV node) and they slow phase 4, yielding a prolonged AP?
|
Class IV antiarrhythmics
|
|
MOA of glycosides?
|
combine with Na/K ATPase of the cardiac cell membrane, inhibiting the Na-K pump
|
|
What happens as a result of glycosides inhibiting the Na-K pump?
|
prevents Na from being pumped out, Na levels rise and this (-) the Na/Ca exchanger (The Na-Ca exchanger normally pumps Na in and Ca out) As a result no Ca is pumped out and levels rise and excess Ca is pumped into the SR and this aids in overall contractility and therefore CO is increased
|
|
What effect do glycosides have on overall cardiac muscle contractility and CO?
|
They aid in overall cardiac muscle contractility and as a result CO is increased
|
|
What agents are used for severe LV systolic dysfunction such as in CHF?
|
glycosides
|
|
change in vision can be one of the first indication of toxicity of what?
|
glycosides
|
|
Cardiac side effects of AV block and arrhythmias d/t glycosides is due primarily to what?
|
decrease in intracellular K
|
|
What agent cannot be used in those with liver problems as it relies on the liver for its metabolism?
|
Digitoxin
|
|
What agent is used instead of Digitoxin?
|
Digoxin - excreted unchanged in the urine
|
|
MOA of Dobutamine and dopamine?
|
beta agonists for the beta-1 receptor - activating adenyl cyclase which converts AMP to cAMP; cAMP activates protein kinase which phosphorylates Ca channels = increase Ca in cells and increased force of contraction
|
|
What agents are PDE inhibitors? (2)
|
inamrinone ( new name for amrinone) and milrinone
|
|
What normally converts cAMP to AMP?
|
PDE - phosphodiesterase
|
|
What is the MOA of PDE (-) ?
|
(-) PDE which normally converts cAMP to AMP therefore incresing cAMP and causing a prolonged action of protein kinase resulting in an increase in Ca = + inotropy
|
|
What may enhance glycoside toxicity?
|
hypokalemia
|
|
What is a common mode for such hypokalemia that may enhance toxicity of glycosides?
|
concomitant use of thiazides or loop diuretics
|